Results From Multicenter Sars-Cov-2 Antibody Prevalence Study In Patients With Short Bowel Syndrome In Germany

Detalles Bibliográficos
Autores principales: Blüthner, E., Pape, U.-F., Blumenstein, I., Wichmann, J., Tacke, F., Moosburner, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032092/
http://dx.doi.org/10.1016/j.clnesp.2022.09.547
_version_ 1784910724037869568
author Blüthner, E.
Pape, U.-F.
Blumenstein, I.
Wichmann, J.
Tacke, F.
Moosburner, S.
author_facet Blüthner, E.
Pape, U.-F.
Blumenstein, I.
Wichmann, J.
Tacke, F.
Moosburner, S.
author_sort Blüthner, E.
collection PubMed
description
format Online
Article
Text
id pubmed-10032092
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-100320922023-03-22 Results From Multicenter Sars-Cov-2 Antibody Prevalence Study In Patients With Short Bowel Syndrome In Germany Blüthner, E. Pape, U.-F. Blumenstein, I. Wichmann, J. Tacke, F. Moosburner, S. Clin Nutr ESPEN Article Published by Elsevier B.V. 2023-04 2023-03-22 /pmc/articles/PMC10032092/ http://dx.doi.org/10.1016/j.clnesp.2022.09.547 Text en Copyright © 2022 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Blüthner, E.
Pape, U.-F.
Blumenstein, I.
Wichmann, J.
Tacke, F.
Moosburner, S.
Results From Multicenter Sars-Cov-2 Antibody Prevalence Study In Patients With Short Bowel Syndrome In Germany
title Results From Multicenter Sars-Cov-2 Antibody Prevalence Study In Patients With Short Bowel Syndrome In Germany
title_full Results From Multicenter Sars-Cov-2 Antibody Prevalence Study In Patients With Short Bowel Syndrome In Germany
title_fullStr Results From Multicenter Sars-Cov-2 Antibody Prevalence Study In Patients With Short Bowel Syndrome In Germany
title_full_unstemmed Results From Multicenter Sars-Cov-2 Antibody Prevalence Study In Patients With Short Bowel Syndrome In Germany
title_short Results From Multicenter Sars-Cov-2 Antibody Prevalence Study In Patients With Short Bowel Syndrome In Germany
title_sort results from multicenter sars-cov-2 antibody prevalence study in patients with short bowel syndrome in germany
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032092/
http://dx.doi.org/10.1016/j.clnesp.2022.09.547
work_keys_str_mv AT bluthnere resultsfrommulticentersarscov2antibodyprevalencestudyinpatientswithshortbowelsyndromeingermany
AT papeuf resultsfrommulticentersarscov2antibodyprevalencestudyinpatientswithshortbowelsyndromeingermany
AT blumensteini resultsfrommulticentersarscov2antibodyprevalencestudyinpatientswithshortbowelsyndromeingermany
AT wichmannj resultsfrommulticentersarscov2antibodyprevalencestudyinpatientswithshortbowelsyndromeingermany
AT tackef resultsfrommulticentersarscov2antibodyprevalencestudyinpatientswithshortbowelsyndromeingermany
AT moosburners resultsfrommulticentersarscov2antibodyprevalencestudyinpatientswithshortbowelsyndromeingermany

Ejemplares similares